Sun Pharma arm picks up 14.6% stake in US company for $13 million
...One of the wholly-owned subsidiaries of the company has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment, Sun Pharmaceutical Industries said in a BSE filing.
Sun Pharma today said its subsidiary has invested $ 13 million (about Rs 88 crore) in the US-based scPharmaceuticals Inc.
"...One of the wholly-owned subsidiaries of the company has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment," Sun Pharmaceutical Industries said in a BSE filing.
It further said: "Consideration for Series B preferred stock acquired is $ 13 million."
ScPharmaceuticals Inc is a United States-based pharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
The stock of Sun Pharma was trading 2.59% higher at Rs 625 on BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.